Emergent BioSolutions Inc.’s EBS share price has dipped by 10.69%, which has investors questioning if this is right time to buy.

Second, volume was impacted by what we believe was a one-time sale of short-dated inventory to the market by a third-party distributor of generic product. And finally, the federal administration ...

State Bank of India (SBI) shares are back in the spotlight with analysts turning bullish after a technical breakout pattern ...

AirSculpt Technologies, Inc.’s AIRS share price has surged by 7.95%, which has investors questioning if this is right time to sell.

Obviously there were highlights in the quarter 3 36% year over year volume growth, double digit revenue growth ... Our ...

Business & Finance is proud to release the annual CMO 100 Index, recognising the top marketing professionals operating in ...

Discover Emergent BioSolutions' Q1 2025 progress: revenue growth, improved liquidity, NARCAN updates, and strategic outlook.